Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
12
self-reported 2–10 band
Founded
2007
19 years
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
None on record
Company type
Public Company
self-reported
Legal entity
1 brand → 1 confirmed entity
ADALTA LIMITED
ABN92120332925
Legal entities
Show as table · AdAlta Ltd: 1 registry entity
| ADALTA LIMITED | ABN 92120332925 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
AdAlta (ASX:1AD) aims to become a leader in cell therapy for cancer, providing a pathway for innovative cellular immunotherapies for solid cancers originating in Asia, and China particularly, to reach western regulated markets. Subsidiary company, AdCella, in-licenses first in class or best in class assets, establishes manufacturing and generates clinical data in Australia under a US IND at substantially lower cost than in the US. We act as a force multiplier for our Asian partners, enabling them to reach western markets at no cost but while sharing the upside with us.
AdAlta also has a portfolio of assets developed using its proprietary i-body technology available for out-licensing, including:
1. AD-214 is a first in class antifibrotic being developed for lung and kidney fibrosis. With two Phase 1 trials complete, it is ready to advance to Phase 2 trials, providing a much needed new option for patients living under a death sentence with degenerative diseases such as Idiopathic Pulmonary Fibrosis.
2. WD-34 is the first anti-body-like molecule to inhibit malaria, babesia and toxoplasma invasion of red blood cells and liver cells across all strains of these parasites, offering the potential to transform seasonal and deployed personnel malaria prophylaxis
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AUBurke Rd; Camberwell, Victoria 3124Primary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
FAQ
Which legal entity operates under AdAlta Ltd?
One Victoria entity on the ABR. ADALTA LIMITED (ABN 92 120 332 925), high confidence.
How many people work at AdAlta Ltd?
The record holds 12 counted staff profiles at January 2026, above the self-reported 2–10 band.
Where does AdAlta Ltd have offices?
One address on record, Australia only. Primary: Burke Rd, Camberwell, Victoria 3124.
Has AdAlta Ltd raised funding?
None linked to this brand.
Which companies are listed alongside AdAlta Ltd?
8 profiles list AdAlta Ltd as a peer — 76th percentile in Biotechnology Research. It lists ten peers of its own. Dimerix Limited and VivaZome Therapeutics list it back.